Metraipolis › archive › dc_1b37ce8ffca0

Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment… — Europe PMC PMID:42806715

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42806715
DOI
10.1111/jrh.70219
License (as archived)
solo-consultazione
Archived
2026-10-16T13:06:33.672Z
SHA-256 of the archived text
e4235795341ced09a6f70c0408046a8ea5e18d2b6f326854fb9915abcdedaaf8
Stable URL of this page
https://metraipolis.com/documento/dc_1b37ce8ffca0

How to cite

Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment… — Europe PMC PMID:42806715 — Europe PMC (en), https://europepmc.org/article/MED/42806715 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1b37ce8ffca0 (Metraipolis archive dc_1b37ce8ffca0, sha256 e4235795341ced09a6f70c0408046a8ea5e18d2b6f326854fb9915abcdedaaf8)
BibTeX
@misc{dc1b37ce8ffca0,
  title = {Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment… — Europe PMC PMID:42806715},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42806715},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1b37ce8ffca0; sha256 e4235795341ced09a6f70c0408046a8ea5e18d2b6f326854fb9915abcdedaaf8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42806715. Agents can read the archived copy with the MCP tool read_document.